IMI

Intermolecular, Inc.
IMI

Delisted

IMI was delisted on the 19th of September, 2019.

43 hedge funds and large institutions have $41.2M invested in Intermolecular, Inc. in 2014 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 16 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more capital inflows, than outflows

Capital inflows: $7.54M | Capital outflows: $6.64M

0.33% more ownership

Funds ownership: 36.7% → 37.03% (+0.33%)

19% less funds holding

Funds holding: 53 → 43 (-10)

38% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 16

53% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 19

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
43
Holders Change
-10
Holders Change %
-18.87%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
10
Reduced
16
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IMI Hedge Fund Activity: Q2 2014 in Review

43 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q2 2014, worth a combined $41.2M — down 14% from $48.1M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of IMI and 9 opened new positions — a net loss of 10 holders — while 16 trimmed existing stakes and 10 added.

The largest buyer was Raging Capital Management, adding an estimated $5.31M. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.06M.

  • 43 institutional investors held Intermolecular, Inc. (IMI) as of Q2 2014, down from 53 in Q1 2014.
  • Funds reported $41.2M of Intermolecular, Inc. stock for Q2 2014, down 14% quarter-over-quarter.
  • 9 funds opened new Intermolecular, Inc. positions in Q2 2014 and 19 closed out, a net change of -10 holders.
  • The largest Intermolecular, Inc. buyer in Q2 2014 was Raging Capital Management, an estimated $5.31M added.
  • The largest Intermolecular, Inc. seller in Q2 2014 was BlackRock Fund Advisors, an estimated $1.06M sold.

Based on aggregated 13F filings for Q2 2014.